Know Your Ports - Oncology Nursing News
2017年12月21日 · A port is typically placed on the right side of the patient’s chest and about 3 to 5 fingerbreadths below the clavicle. The insertion scar provides a useful landmark, because the port is usually located 0.5 to 1 inch below the surgical incision. Bringing a patient who has large amounts of breast tissue to a fully upright position, with the ...
Oncology Nursing News
October 7th 2024. Panelists discuss how axatilimab, a novel therapy for chronic graft-versus-host disease (cGVHD), functions through a unique mechanism of action compared to other treatments, highlighting its potential role in cGVHD management and presenting key findings from the AGAVE-201 trial that demonstrate its efficacy and safety profile.
What Are Professional Boundaries and Why Do They Matter?
2017年10月4日 · The National Council of State Boards of Nursing defines a boundary crossing as a “brief excursion across professional lines of behavior.”. Your action may be unplanned and honestly intended to meet a patient’s or a caregiver’s need. Consider the following: It seems like a harmless, kind gesture. But questions to ask yourself are: 1.
Opinion: The Media May Have Oversold AOH1996, City of Hope's …
2023年9月20日 · Opinion: The Media May Have Oversold AOH1996, City of Hope's Pioneering Cancer Drug. September 20, 2023. By Amanda Brink, DNP, APRN, FNP-BC, AOCNP. Opinion. Article. AOH1996, a drug named in honor of Anna Olivia Healy, is being tested in a phase 1 trial. As nurses, we must help our patients understand that phase 1 trials represent very early ...
PD-L1 CPS Score Could Direct Treatment Decisions in Recurrent ...
2022年4月1日 · PD-L1 combined positive score (CPS) may serve to predict whether a patient with PD-L1–expressing recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) will receive optimal benefit with pembrolizumab (Keytruda) alone vs in combination with chemotherapy or with cetuximab (Erbitux) plus chemotherapy, according to an efficacy ...
A Rundown of New Infusion Therapies - Oncology Nursing News
2020年11月12日 · A Rundown of New Infusion Therapies. November 11, 2020. By Brielle Benyon. Article. A pharmacist provides an overview of new intravenous cancer therapies that were approved in 2020. In 2020, the FDA approved more than 50 new cancer treatment regimens, bringing 19 new drugs to the market. While the majority of …
Six Ways Nurses Can Advocate for Patients - Oncology Nursing …
2018年8月30日 · Six Ways Nurses Can Advocate for Patients. August 30, 2018. By Alene Nitzky, PhD, RN, OCN. Article. This is the first in a 3-part series about nurses as advocates within healthcare. Many nurses think of advocacy as the most important role we play in patient care. We need to remember that to best serve patients, we must have our own house in order.
Understanding Why Black Women Have Denser Breasts May Help …
2015年4月21日 · Since the fibroglandular tissue appears as white on the mammogram, it makes it difficult to visually detect breast cancers. Research has shown that women who have the highest breast density have a 4 to 6 times greater risk for breast cancer compared with women with lower breast density. Although several studies have previously shown that black ...
"Triggers Tool" Gets Patients Into Palliative Care Earlier
2017年9月13日 · A new tool is helping healthcare providers determine who will benefit from palliative care starting early in the course of their treatment for cancer, according to the authors of a pilot study whose results were presented Sept. 9, during the 2017 European Society for Medical Oncology (ESMO) Congress in Madrid, Spain. The “Triggers” tool was ...
Breast Cancer Outcomes Can Be Predicted by Residual Cancer …
2019年12月16日 · Residual cancer burden (RCB) after neoadjuvant chemotherapy has been shown to be an accurate long-term predictor of disease recurrence and survival across all breast cancer subtypes, according to data from a large meta-analysis presented at the 2019 San Antonio Breast Cancer Symposium. 1. Several studies have demonstrated independent validation ...